tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market

Protagonist Therapeutics (PTGX) Ownership - Who Owns Protagonist Therapeutics?

Compare
681 Followers

Protagonist Therapeutics (PTGX) Ownership Overview

1.72%15.16%50.31%22.69%10.11%
50.31% Other Institutional Investors
22.69% ETFs
10.11% Public Companies and Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 88.16% of the company’s stock is owned by Institutional Investors, 1.72% is owned by Insiders, and 10.11% is owned by Public Companies and Individual Investors.
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 65.47% of the company’s stock is owned by Institutional Investors, 1.72% is owned by Insiders, and 22.69% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 11, 2025
xxxxxxxxxxxxx
$1125400
Apr 23, 2025
xxxxxxxxxxxxx
$80776
Mar 14, 2025
xxxxxxxxxxxxx
$1700850
Mar 14, 2025
xxxxxxxxxxxxx
$1462553

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,801,188Institution10.97%371,752,936
6,107,006Institution9.85%333,808,948
3,703,853Institution5.98%202,452,605
2,878,214Institution4.64%157,323,177
1,400,142Institution2.26%76,531,762
1,091,271Institution1.76%59,648,873
1,019,104Institution1.64%55,704,225
931,890Institution1.50%50,937,107
897,699Institution1.45%49,068,227
622,971Institution1.01%34,051,595

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,878,214Institution4.64%157,323,177
1,019,104Institution1.64%55,704,225
622,971Institution1.01%34,051,595
594,493Institution0.96%32,494,987
423,913Institution0.68%23,171,085
403,401Institution0.65%22,049,899
345,217Institution0.56%18,869,561
326,243Institution0.53%17,832,442
279,435Institution0.45%15,273,917
216,046Institution0.35%11,809,074

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,562,854Institution5.75%194,745,600
1,972,956Institution3.18%93,656,221
1,475,361Institution2.38%80,643,232
926,592Institution1.49%43,985,322
530,123Institution0.86%28,976,523
511,567Institution0.83%27,962,252
507,004Institution0.82%28,579,815
475,528Institution0.77%26,805,513
358,039Institution0.58%19,570,412
354,045Institution0.57%19,352,100

FAQ

Who Owns Protagonist Therapeutics (PTGX)?
According to the latest TipRanks data, approximately 50.31% of the company's stock is held by institutional investors, 1.72% is held by insiders, and 10.11% is held by retail investors.
    What percentage of Protagonist Therapeutics (PTGX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 50.31% of Protagonist Therapeutics (PTGX) stock is held by institutional investors.
      What percentage of Protagonist Therapeutics (PTGX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 10.11% of Protagonist Therapeutics (PTGX) stock is held by retail investors.
        Who owns the most shares of Protagonist Therapeutics (PTGX)?
        iShares owns the most shares of Protagonist Therapeutics (PTGX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis